Overview

Zinc Effect on Inflammation and Cardiovascular Risk in HIV

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
To study the effect of short-term zinc supplementation on improving inflammation, metabolic, and cardiovascular risk among HIV infected patients on stable anti-retroviral therapy
Phase:
Early Phase 1
Details
Lead Sponsor:
University Hospitals Cleveland Medical Center
Collaborator:
Case Western Reserve University